(3aR,8aS)-2-(4-(Trifluoromethyl)pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
97%
- Product Code: 55619
CAS:
2126903-00-0
| Molecular Weight: | 304.2600 g./mol | Molecular Formula: | C₁₆H₁₁F₃N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its unique structure, featuring a trifluoromethylpyridine moiety fused with an indenoxazole ring, makes it a valuable scaffold for developing potential therapeutic agents. Researchers focus on its application in designing inhibitors for specific enzymes or receptors, particularly those involved in inflammatory diseases, cancer, and neurological disorders. The trifluoromethyl group enhances the compound's metabolic stability and binding affinity, making it a promising candidate for drug discovery projects. Additionally, its rigid bicyclic structure is explored for creating novel compounds with improved pharmacokinetic properties.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | ฿1,980.00 |
+
-
|
(3aR,8aS)-2-(4-(Trifluoromethyl)pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its unique structure, featuring a trifluoromethylpyridine moiety fused with an indenoxazole ring, makes it a valuable scaffold for developing potential therapeutic agents. Researchers focus on its application in designing inhibitors for specific enzymes or receptors, particularly those involved in inflammatory diseases, cancer, and neurological disorders. The trifluoromethyl group enhances the compound's metabolic stability and binding affinity, making it a promising candidate for drug discovery projects. Additionally, its rigid bicyclic structure is explored for creating novel compounds with improved pharmacokinetic properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :